VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,682 | -30.7% | 42,056 | +5.8% | 0.01% | -29.4% |
| Q2 2023 | $262,018 | +37.6% | 39,760 | +41.8% | 0.02% | +54.5% |
| Q1 2023 | $190,351 | +8.3% | 28,034 | +17.9% | 0.01% | +22.2% |
| Q4 2022 | $175,705 | +273.8% | 23,776 | +391.8% | 0.01% | +350.0% |
| Q3 2020 | $47,000 | -45.3% | 4,834 | -35.6% | 0.00% | -60.0% |
| Q2 2020 | $86,000 | +28.4% | 7,502 | +15.4% | 0.01% | +25.0% |
| Q1 2020 | $67,000 | 0.0% | 6,502 | +58.9% | 0.00% | +33.3% |
| Q4 2019 | $67,000 | +857.1% | 4,093 | +658.0% | 0.00% | – |
| Q3 2019 | $7,000 | -46.2% | 540 | -42.9% | 0.00% | -100.0% |
| Q2 2019 | $13,000 | -61.8% | 946 | -48.4% | 0.00% | -50.0% |
| Q1 2019 | $34,000 | -30.6% | 1,834 | -3.0% | 0.00% | -33.3% |
| Q4 2018 | $49,000 | +133.3% | 1,890 | +104.8% | 0.00% | +200.0% |
| Q3 2018 | $21,000 | -64.4% | 923 | -70.0% | 0.00% | -75.0% |
| Q2 2018 | $59,000 | -56.0% | 3,074 | -61.5% | 0.00% | -60.0% |
| Q1 2018 | $134,000 | +857.1% | 7,976 | +739.6% | 0.01% | +900.0% |
| Q4 2017 | $14,000 | -48.1% | 950 | -37.6% | 0.00% | -50.0% |
| Q3 2017 | $27,000 | +22.7% | 1,523 | +14.5% | 0.00% | 0.0% |
| Q2 2017 | $22,000 | -51.1% | 1,330 | -52.5% | 0.00% | -60.0% |
| Q4 2016 | $45,000 | +50.0% | 2,800 | +55.6% | 0.01% | +66.7% |
| Q3 2016 | $30,000 | -18.9% | 1,800 | -46.2% | 0.00% | -40.0% |
| Q2 2016 | $37,000 | +131.2% | 3,346 | +71.5% | 0.01% | +150.0% |
| Q1 2016 | $16,000 | +45.5% | 1,951 | +62.6% | 0.00% | 0.0% |
| Q4 2015 | $11,000 | -86.2% | 1,200 | -81.0% | 0.00% | -81.8% |
| Q2 2015 | $80,000 | +21.2% | 6,300 | -10.0% | 0.01% | +10.0% |
| Q1 2015 | $66,000 | -85.8% | 7,000 | -75.7% | 0.01% | -83.6% |
| Q2 2014 | $466,000 | +1403.2% | 28,803 | +1415.9% | 0.06% | +1425.0% |
| Q1 2014 | $31,000 | -81.3% | 1,900 | -85.8% | 0.00% | -85.7% |
| Q4 2013 | $166,000 | – | 13,375 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |